Biomarkers in Cancer Immunotherapy: Oasis or Mirage?

The SITC 2015 Presentation Archive is supported through a generous contribution from AstraZeneca/MedImmune.

Access slide decks and video via the links in the schedule below.

= PDF of slides is available

= Presentation video is available

Program Schedule

Sunday, November 8, 2015

9:30 – 9:35 a.m.	Welcome and Introductions
9:35 – 9:45 a.m.	Science of Biomarkers     Daniel S. Chen, MD, PhD – Genentech
9:45 – 10:15 a.m.	Biomarkers for Cancer Immunotherapy Debate     Pro: Daniel S. Chen, MD, PhD – Genentech Con: Steven Averbuch, MD – Bristol-Myers Squibb
10:15 – 11:05 a.m.	Panel Discussion with Open Audience Questions   Steve Averbuch, MD – Bristol-Myers Squibb Thomas Gajewski, MD, PhD – University of Chicago Daniel S. Chen, MD, PhD – Genentech Jeffrey Weber, MD, PhD – H. Lee Moffitt Cancer Center
11:05 – 11:35 a.m.	Other Topics in Biomarkers Discussion     Blood-Based:  Michael D. Kalos, PhD – Eli Lilly and Company Tissue Markers:  Naiyer Rizvi, MD – Columbia University Medical Center
11:35 – 11:55 a.m.	Future Biomarkers Panel Discussion     Lisa H. Butterfield, PhD – University of Pittsburgh Suzanne L. Topalian, MD – John Hopkins University Michael D. Kalos, PhD – Eli Lilly and Company Naiyer Rizvi, MD – Columbia University Medical Center
11:55 – Noon	Closing Remarks